All TACE procedures were performed by two interventional radiologists (with more than 10 years of experience in interventional radiology) to ensure consistency (Figure 1). Hepatic artery angiography was performed using a 5-Fr catheter to identify the tumor and feeder (s). Then, superselective catheterization of the feeding artery was performed using a 2.0 F microcatheter (Progreat, Terumo Corporation, Tokyo, Japan) followed by conventional TACE. The amount of pirarubicin (THP; 60-80 mg; Shenzhen Meirui Pharmaceutical Co., Ltd. China) and iodized oil (Jiangsu Hengrui Medicine Co. Ltd., Jiangsu, China) used was 10 to 20 mg (average 14.3 mg) and 4-6ml (average 5.1 ml), respectively. Finally, after the lipiodol was evenly deposited in the tumor, the tumor feeding artery was completely embolized with microspheres (100-300lm; Jiangsu Hengrui Medicine Co. Ltd., Jiangsu, China) (Figure 2(A)).
Iodized oil
Manufactured by Jiangsu Hengrui Medicine
Sourced in China
Iodized oil is a laboratory reagent used in various analytical and research applications. It is a clear, yellowish liquid composed of iodinated fatty acids derived from plant or animal oils. The primary function of iodized oil is to provide a source of iodine for various chemical reactions and procedures.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using iodized oil
1
Transarterial Chemoembolization for Liver Tumors
2
Superselective TACE for Liver Cancer
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Two experienced interventional radiologists (with more than 10 years of experience each) performed all TACE procedures. First, a 5-Fr catheter was used for hepatic artery angiography to identify the tumor and its feeder(s). Subsequently, a 2.0 F microcatheter (Progreat, Terumo Corporation, Tokyo, Japan) was used for superselective catheterization of the feeding artery. Pirarubicin (THP; 60–80 mg; Shenzhen Meirui Pharmaceutical Co., Ltd. China) and iodized oil (Jiangsu Hengrui Medicine Co. Ltd., Jiangsu, China) were administered at an average dose of 10–20 mg (average 14.3 mg) and 4–6 ml (average 5.1 ml), respectively. Finally, microspheres (100–300 μm; Jiangsu Hengrui Medicine Co. Ltd., Jiangsu, China) were used for complete embolization of the artery supplying the tumor after lipiodol was evenly deposited in the tumor ( Fig. 1 ). ![]()
Patients with HCC with a diameter of 3 mm adjacent to the diaphragm; A. The tumor first completes the transcatheter arterial chemoembolization under the guidance of CBCT;B. HCC is marked by iodized oil; C. preoperative puncture route planning under the guidance of CBCT; D-F. The patient completes the MWA process immediately after TACE treatment
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!